Kbp Biosciences
2007
FOUNDED
PRIVATE
STATUS
Series A
LATEST DEAL TYPE
$76M
LATEST DEAL AMOUNT
13
INVESTORS
Description
Developer of therapies in areas of unmet medical need in Cardiovascular, Infectious Disease, Respiratory, Inflammatory and Autoimmune diseases. The company is dedicated to the research, development and commercialization of innovative medicines in areas of unmet medical need. It is based on cutting-edge new drug development ideas and its own medicinal chemistry and CMC strengths, together with internal/external clinical development and regulatory expertise, the company devotes its resources towards identifying and progressing innovative NCEs with known mechanisms of action in validated targets for the treatment of patients with unmet medical needs in cardio-renal, infectious disease, respiratory, inflammatory and autoimmune diseases.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- 116 Village Boulevard
- Suite 210
- Princeton, NJ 08540
- United States
+1 (609) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Kbp Biosciences’s full profile, request a free trial.
Kbp Biosciences Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 05-Jan-2018 | $76M | 0000 | 00000 | Completed | Generating Revenue |
Kbp Biosciences Competitors (49)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Jounce Therapeutics | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 0000 000000000000 | Formerly VC-backed | Geneva, Switzerland | 000.00 | 000000&0 | 000.00 | |
| 00000 000000000000 | Venture Capital-Backed | Watertown, MA | 000 | 00000 | 000000000 | 00000 |
| 000000 00000000000 | Formerly VC-backed | Burlingame, CA | 00 | 00000 | 00000000 | 00000 |
| 00000000 | Venture Capital-Backed | Cambridge, MA | 00 | 000.00 | 00000000000 | 000.00 |
Kbp Biosciences Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| 3E Bioventures Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Advantech Capital Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| Bay City Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| CASH Capital | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Castech(China) | Corporation | Minority | 000 0000 | 000000 0 |
Kbp Biosciences Executive Team (6)
| Name | Title | Board Seat |
Contact Info |
|---|---|---|---|
| Fred Yang Ph.D | Chief Development Officer | ||
| Vince Benn Ph.D | Vice President, Regulatory & Medical Affairs | ||
| Robert Segal MD | Deputy Chief Medical Officer |
3 Former Executives
You’re viewing 3 of 6 executives. Get the full list »Kbp Biosciences Board Members (5)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Benjamin Qiu | Self | Board Member | 000 0000 | |
| Bing Wang Ph.D | Self | Board Member | 000 0000 | |
| Frederick Craves Ph.D | Bay City Capital | Board Member | 000 0000 | |
| Huang Zhenhua Ph.D | Kbp Biosciences | Chairman & Founder | 000 0000 |
1 Former Board Member
You’re viewing 4 of 5 board members. Get the full list »